Prognosis of patients with hepatocellular carcinoma treated with immunotherapy – development and validation of the CRAFITY score-Reference-Cited by-同舟云学术

Prognosis of patients with hepatocellular carcinoma treated with immunotherapy – development and validation of the CRAFITY score

Published:2022-02 Issue:2 Volume:76 Page:353-363
ISSN:0168-8278
Container-title:Journal of Hepatology
language:en
Short-container-title:Journal of Hepatology

Author:

Scheiner Bernhard^ORCID,Pomej Katharina^ORCID,Kirstein Martha M.,Hucke Florian^ORCID,Finkelmeier Fabian,Waidmann Oliver,Himmelsbach Vera,Schulze Kornelius,von Felden Johann,Fründt Thorben W.,Stadler Marc,Heinzl Harald^ORCID,Shmanko Kateryna,Spahn Stephan,Radu Pompilia^ORCID,Siebenhüner Alexander R.,Mertens Joachim C.,Rahbari Nuh N.^ORCID,Kütting Fabian,Waldschmidt Dirk-Thomas,Ebert Matthias P.,Teufel Andreas,De Dosso Sara,Pinato David J.^ORCID,Pressiani Tiziana,Meischl Tobias^ORCID,Balcar Lorenz,Müller Christian,Mandorfer Mattias,Reiberger Thomas,Trauner Michael^ORCID,Personeni Nicola^ORCID,Rimassa Lorenza^ORCID,Bitzer Michael,Trojan Jörg,Weinmann Arndt^ORCID,Wege Henning,Dufour Jean-François,Peck-Radosavljevic Markus,Vogel Arndt,Pinter Matthias^ORCID

Publisher

Elsevier BV

Subject

Hepatology

Reference57 articles.

1. Cancer and liver cirrhosis: implications on prognosis and management;Pinter;ESMO Open,2016

2. EASL clinical practice guidelines: Management of hepatocellular carcinoma;J Hepatol,2018

3. Review article: systemic treatment of hepatocellular carcinoma;Pinter;Aliment Pharmacol Ther,2018

4. The current landscape of immune checkpoint blockade in hepatocellular carcinoma: a review;Pinter;JAMA Oncol,2021

5. Pembrolizumab as second-line therapy in patients with advanced hepatocellular carcinoma in KEYNOTE-240: a randomized, double-blind, phase III trial;Finn;J Clin Oncol,2020

Cited by 159 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immunotherapy for hepatocellular carcinoma;JHEP Reports;2024-10

2. Biomarkers for diagnosis and therapeutic options in hepatocellular carcinoma;Molecular Cancer;2024-09-06

3. CT radiomics-based biomarkers can predict response to immunotherapy in hepatocellular carcinoma;Scientific Reports;2024-08-28

4. The Predictive Significance of Serum C-Reactive Protein in Hepatocellular Carcinoma with Microvascular Invasion;2024-08-17

5. Predictive value of circulating immune cell changes in response to PD-1 blockade and TKI therapy in patients with hepatocellular carcinoma;Clinics and Research in Hepatology and Gastroenterology;2024-08